Atlas Trials

A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg Tablets

Clinical trial NCT03437564 · COMPLETED

Trial details

NCT number
NCT03437564
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Adult Participants
Start date
2018-02-16
Primary completion
2018-04-13
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.